On the mechanism of hypocholesterolemic effects of polyunsaturated lipids.
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001646:Bile / Q000187:drug effects / Q000378:metabolism; D001647:Bile Acids and Salts / Q000037:antagonists & inhibitors / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D002769:Cholelithiasis / Q000517:prevention & control; D002784:Cholesterol / Q000032:analysis / Q000096:biosynthesis / Q000097:blood / Q000378:metabolism*; D002994:Clofibrate / Q000494:pharmacology; D004041:Dietary Fats / Q000494:pharmacology; D005224:Fats, Unsaturated / Q000494:pharmacology*; D005243:Feces / Q000032:analysis; D006801:Humans; D008041:Linoleic Acids / Q000097:blood; D008075:Lipoproteins, HDL / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008099:Liver / Q000378:metabolism; D008823:Micelles; D010743:Phospholipids / Q000378:metabolism
D000924:Anticholesteremic Agents; D001647:Bile Acids and Salts; D004041:Dietary Fats; D005224:Fats, Unsaturated; D008041:Linoleic Acids; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008823:Micelles; D010743:Phospholipids; D002784:Cholesterol; D002994:Clofibrate